Research study Program year 2021 Source: CMS Open Payments

Phase 2b - SLE Dose-Finding

Research payments

$1,661,016

84 payments

Through program year 2021, $1,661,016 in research payments was reported against Phase 2b - SLE Dose-Finding, across 84 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$1,607,900	80
2020	Research	$53,116	4

Breakdown

Who paid Research payments · program years 2020–2021

Amgen Inc. $1,661,016 84 payments

Who received the money Research payments · program years 2020–2021

Hospital Of The Univ Of Penna Teaching hospital · PA $245,275 3 payments
Clinic Of Robert Hozman, MD - Clinical Investigational Specialists, INC Organisation paid for research $141,197 2 payments
University Of Alabama Hospital Teaching hospital · AL $93,910 2 payments
New York University Langone Orthopedic Center Organisation paid for research $76,007 3 payments
Medvin Clinical Research Organisation paid for research $74,917 2 payments
Yale University Organisation paid for research $59,266 4 payments
Djl Clinical Research Pllc Organisation paid for research $58,535 2 payments
Joint And Muscle Research Institute Organisation paid for research $56,900 2 payments
Medical University of South Carolina Organisation paid for research $55,711 2 payments
The Emory Clinic Organisation paid for research $54,962 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.